Even though there are studies showing an effective and safe reduction of glycaemic parameters with initial combination therapies with DPP-4 inhibitors, initial combinations are not generally recommended in the new treatment recommendations (85)
A master protocol for orforglipron (LY3502970) in participants with hypertension and obesity or overweight: (ATTAIN-Hypertension screening)
Retatrutide is an investigational once-weekly triple agonist that targets GLP-1, GIP, and glucagon receptors
Step-by-Step Injection Guide Step 1: Wash Your Hands Thoroughly wash your hands with soap and water to maintain hygiene
In India's evolving pharmaceutical landscape, deep discounting cannot substitute for clinical confidence, robust post-market surveillance, and comprehensive lifestyle counseling
Los resultados prometedores de este estudio llevaron a la aprobacin de la liraglutida por parte de la FDA para reducir el riesgo de eventos cardiovasculares mayores (MACE, por sus siglas en ingls) como ataque cardaco, accidente cerebrovascular y muerte en adultos con diabetes Tipo 2 y enfermedad cardiovascular establecida
